Overview
Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe
Status:
Completed
Completed
Trial end date:
2014-11-01
2014-11-01
Target enrollment:
0
0
Participant gender:
Male
Male
Summary
The purpose of this study is to investigate the pharmacokinetic drug interactions between Rosuvastatin and Ezetimibe in Healthy Male SubjectsPhase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Hanmi Pharmaceutical Company LimitedTreatments:
Ezetimibe
Rosuvastatin Calcium
Criteria
Inclusion Criteria:- Healthy male volunteer, age 19~45 years
- The result of Body Mass Index(BMI) is not less than 19 kg/m2 , no more than 28 kg/m2
- Subject who has the ability to comprehend the study objectives, contents and the
property of the study drug before participating in the trial.
Exclusion Criteria:
- Presence of medical history or a concurrent disease that may interfere with treatment
and safety assessment or completion of this clinical study
- History of relevant drug allergies or clinically significant hypersensitivity
reaction.